Literature DB >> 23291952

Development of a Vero cell DNA reference standard for residual DNA measurement in China.

Shouchun Cao1, Guanmu Dong, Jianrong Tang, Jia Li, Jinghua Liu, Leitai Shi, Changgui Li, Junzhi Wang.   

Abstract

This collaborative study developed a Vero cell DNA reference for standardizing dot blot hybridization, an assay widely employed to measure residual DNA contents of viral vaccines prepared with Vero cells. High purity of Vero cell DNA was extracted and characterized by Hind III enzyme digestion and DNA sequencing. Then, with a cooperative calibration, the concentration of Vero cell DNA reference bulk solution was determined (64.0 ± 1.9 μg/mL, OD 260/OD 280 = 1.87) and diluted (40 ng/mL) with Tris-EDTA buffer containing bovine serum albumin as freeze-dried excipients. With industrial filling apparatus, the diluted bulk was loaded into ampoules (0.5 mL each) which were heat sealed after nitrogen filling. Finally, a collaborative study showed that the Vero cell DNA reference could reach a sensitivity of 1 to 5 pg/dot and maintained good stability after accelerated destruction test. The successful establishment of the Vero cell DNA quantitative reference will facilitate the standardization of dot blot hybridization for testing residual host cell DNA.

Entities:  

Keywords:  Vero cell genomic DNA; dot blot; quantitative reference standard; standardization

Mesh:

Substances:

Year:  2013        PMID: 23291952      PMCID: PMC3859766          DOI: 10.4161/hv.22699

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  7 in total

1.  Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard.

Authors:  Shingo Niimi; Tadashi Oshizawa; Masaaki Naotsuka; Sumiaki Ohba; Akira Yokozawa; Tomoyo Murata; Takao Hayakawa
Journal:  Biologicals       Date:  2002-03       Impact factor: 1.856

2.  Arrangement of a highly repeated DNA sequence in the genome and chromatin of the African green monkey.

Authors:  D S Singer
Journal:  J Biol Chem       Date:  1979-06-25       Impact factor: 5.157

3.  WHO Expert Committee on Biological Standardization.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2006

4.  WHO Expert Committee On Biological Standardization.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1998

5.  A collaborative study on DNA quantitation in biological products.

Authors:  J S Robertson; A B Heath
Journal:  Biologicals       Date:  1995-09       Impact factor: 1.856

6.  Development and calibration of a standard for the protein content of granulocyte colony-stimulating factor products.

Authors:  Kai Gao; Chunming Rao; Lei Tao; Chunmei Han; Xinchang Shi; Lan Wang; Wenhong Fan; Lei Yu; Junzhi Wang
Journal:  Biologicals       Date:  2012-01-30       Impact factor: 1.856

7.  Production and certification of NIST Standard Reference Material 2372 Human DNA Quantitation Standard.

Authors:  Margaret C Kline; David L Duewer; John C Travis; Melody V Smith; Janette W Redman; Peter M Vallone; Amy E Decker; John M Butler
Journal:  Anal Bioanal Chem       Date:  2009-04-18       Impact factor: 4.142

  7 in total
  5 in total

Review 1.  Progress on the research and development of inactivated EV71 whole-virus vaccines.

Authors:  Zheng-Lun Liang; Qun-Ying Mao; Yi-Ping Wang; Feng-Cai Zhu; Jing-Xin Li; Xin Yao; Fan Gao; Xing Wu; Miao Xu; Jun-Zhi Wang
Journal:  Hum Vaccin Immunother       Date:  2013-06-06       Impact factor: 3.452

Review 2.  Regulatory science accelerates the development of biotechnology drugs and vaccines by NIFDC.

Authors:  Zhenglun Liang; Qunying Mao; Yiping Wang; Changgui Li; Kai Gao; Junzhi Wang
Journal:  Emerg Microbes Infect       Date:  2014-09-17       Impact factor: 7.163

3.  Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA.

Authors:  Jie Shao; Fan Gao; Hui-Juan Lin; Qun-Ying Mao; Pan Chen; Xing Wu; Xin Yao; Wei Kong; Zheng-Lun Liang
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

4.  The development of China's vaccine industry in the past decade: the perspective from drug regulatory science.

Authors:  Guanjie Wang; Mingli Shao
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

5.  Development of a reference standard of Escherichia coli DNA for residual DNA determination in China.

Authors:  Lan Wang; Chunming Rao; Kai Gao; Yonghong Li; Zhihao Fu; Hua Bi; Junzhi Wang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.